[Current pharmacotherapy of obesity].
Krysiak
R
R
Okopień
B
B
Madej
A
A
Belowski
D
D
Herman
Z S
ZS
D018663:Adrenergic Agents / Q000627:therapeutic use; D000818:Animals; D001067:Appetite Depressants / Q000627:therapeutic use; D005227:Fatty Acids / Q000008:administration & dosage; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D020738:Leptin / Q000378:metabolism; D008049:Lipase / Q000037:antagonists & inhibitors; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism; D000077403:Orlistat; D018490:Serotonin Agents / Q000627:therapeutic use; D013395:Sucrose / Q000008:administration & dosage / Q000031:analogs & derivatives
D018663:Adrenergic Agents; D001067:Appetite Depressants; D005227:Fatty Acids; D007783:Lactones; D020738:Leptin; D018490:Serotonin Agents; D013395:Sucrose; C013692:sucrose polyester; D000077403:Orlistat; D008049:Lipase